BMP Sunstone Corp. (BJGP)

All Comments on BJGP

  • commenter
    buffetsmento
    r
    May 12 09:39 PM
    General Discussion on BJGP
    definite buy. close to 52 week low despite executing on all fronts. record revenue and margins will be reported may 19th. also awating analyst upgrade anytime now. easy double digits by end of year. Reply
  • commenter
    Tom B
    May 12 09:55 AM
    China Biopharma: What’s Not to Like? [view article]
    John Pseudonym has it "dead" right. If you have been burned by frivolous lawsuits against your favorite Pharma companies (Merck and Vioxx), just wait for the flood of LEGIT lawsuits off-shoring will usher in. Litigation is a great killer of wealth. Reply
  • commenter
    David White
    May 12 01:36 AM
    China Biopharma: What’s Not to Like? [view article]
    That was an interesting article. Those stocks are fairly big players. However, they don't seem to have as much potential as some of the smaller Chinese Biotechs. What do you think of such stocks as SOBM, HFGB, CKGT, RHGP, SVA, CPHI, and CHBT? I actually like SOBM. It has a block buster malaria vaccine in clinical tests (promising so far). This is currently scheduled to complete (hopefully successfully) clinical trials in 2012. Meanwhile it has other drugs that are doing well. Apparently a not-quite blockbuster drug is due out in April 2009. It is currently selling several newly released drugs. Perhaps it will be profitable for the first time this year??? Next year is supposed to be even better. It is getting money from the W.H.O. and the Chinese government, so you know its science is respected.
    Many of the other companies I have listed are in similar circumstances. Some are already substantially profitable. What do you think about investing in these??     Reply
  • commenter
    John
    Pseudonym
    May 11 11:08 AM
    China Biopharma: What’s Not to Like? [view article]
    Wait until it's shown that those Chinese drugs are killing people through low quality standards...no thanks! Reply
  • commenter
    SeekingAlpha
    Editors
    Apr 06 05:20 AM
    My Website
    General Discussion on BJGP
    Is this a buy or a sell? Reply
  • commenter
    jade_guanyin
    Feb 25 10:51 PM
    New China Biopharma Investments [view article]
    "Because the target is listed on the Hong Kong exchange, the company will not require regulatory approval. "

    As for the above stated remarks made on SHA, just a minor correction, the targetted company is NOT a public company listed in HK Stock Exchange.

    Jade @ Beijing     Reply
  • commenter
    Timothy J.
    Roe
    Jan 22 01:23 PM
    Parsing Beijing Med-Pharm Corp.'s Latest Results [view article]
    Good point 142619. Revs and earnings should improve as these deals are folded in. BJGP is at a bit of a tough spot as they digest the acquisitions and incorporate the individual financials without the benefit of increased operational efficiencies that will likely be seen in coming quarters. Increasing the number of products that they can push through their newly built distribution "pipeline" should also help margins. Reply
  • commenter
    User 142619
    Jan 21 08:15 PM
    Parsing Beijing Med-Pharm Corp.'s Latest Results [view article]
    Nice commentary. Keep in mind that the Boots JV will close by the end of January and that 10% of revs from Guaangzhou Pharma will hit BJGP's bottom line. They'll also get additional rev from Rongheng when that closes (likely in Q1) Reply
  • commenter
    Long-Short
    Guy
    Jan 19 06:00 PM
    Parsing Beijing Med-Pharm Corp.'s Latest Results [view article]
    Any more thoughts on catalysts and valuation? Reply
Loading...
Symbols:
Authors:
Quick Links: